Characteristic | Treatment preference | P value | ||
---|---|---|---|---|
Salicylic acid | Cryotherapy | No preference | ||
Type of verruca | ||||
Mosaic | 5/28 (17.9) | 16/86 (18.6) | 24/104 (23.1) | 0.73 |
Non-mosaic | 23/28 (82.1) | 70/86 (81.4) | 80/104 (76.9) | |
Duration of verruca (months) | ||||
N | 26 | 80 | 100 | |
Mean(sd) | 30.7 (27.5) | 22.9 (19.6) | 26.6 (27.3) | 0.43 |
Median (interquartile range) | 24.0 (12.0, 39.0) | 18.0 (9.5, 29.0) | 16.8 (8.5, 36.0) | |
Number of verrucae at baseline | ||||
N | 28 | 86 | 101 | |
Mean (sd) | 4.3 (4.5) | 3.8 (6.6) | 3.3 (3.3) | 0.50 |
Median (interquartile range) | 3.0 (1.0, 5.5) | 2.0 (1.0, 4.0) | 2.0 (1.0, 4.0) | |
Previous treatment for current verruca | ||||
Yes | 23/28 (82.1) | 66/84 (78.6) | 79/104 (76.0) | 0.78 |
No | 5/28 (17.9) | 18/84 (21.4) | 25/104 (24.0) | |
Type of previous treatment* | ||||
Self-treatment | 21/23 (91.3) | 53/66 (80.3) | 73/80 (91.3) | 0.15 |
Podiatrist/chiropodist | 5/23 (21.7) | 23/66 (34.9) | 20/79 (25.3) | 0.34 |
GP | 10/23 (43.5) | 30/66 (45.5) | 27/80 (33.8) | 0.32 |
Trial investigating verruca treatments | 0/23 (0.0) | 2/66 (3.0) | 0/79 (0.0) | 0.41 |
Other | 3/23 (13.0) | 6/66 (9.1) | 5/79 (6.3) | 0.50 |